The role of mitogen-activated protein kinase and protein kinase C in fibronectin production in human vascular smooth muscle cells.
The role of mitogen-activated protein kinase and protein kinase C in fibronectin production in human vascular smooth muscle cells.
复制标题
丝裂原激活蛋白激酶和蛋白激酶 C 在人血管平滑肌细胞纤连蛋白产生中的作用。
DOI:
10.1006/jsre.1999.5646
复制
发表时间:
1999
期刊:
影响因子:
--
通讯作者:
Kent,KC
中科院分区:
文献类型:
--
作者:
Kaiura,TL;Itoh,H;Kent,KC
BackgroundAfter evaluating various growth factors, cytokines, and extracellular matrix (ECM) proteins, we found that the most potent agonists of smooth muscle cell (SMC) fibronectin (Fn) production were transforming growth factor-beta (TGF-β) and epidermal growth factor (EGF). To determine the possible signaling pathways involved in the production of this matrix protein, we investigated the role of the intracellular proteins, protein kinase C (PKC) and mitogen-activated protein kinase (MAP-K), in TGF-β- and EGF-induced human vascular SMC Fn production.Materials and MethodsAfter stimulation of human SMCs with TGF-β (10 ng/ml) and EGF (100 ng/ml), Fn in the cell medium was assayed by immunoblotting using a specific antibody. PKC was activated by brief stimulation of SMC with phorbol 12,13-dibutyrate (PDBu) and inhibited by downregulation with PDBu or the inhibitor, GF109203X. MAP-K was inhibited with PD098059.ResultsPKC activation increased basal and synergistically enhanced TGF-β- and EGF-induced Fn production. However, inhibition of PKC by downregulation and GF109203X did not diminish Fn production by TGF-β and EGF. Surprisingly, these two methods of inhibition slightly increased basal and agonist-induced Fn production. The MAP-K kinase inhibitor, PD098059, produced an almost complete inhibition of EGF and a partial inhibition of TGF-β-induced Fn production.ConclusionsActivation of PKC stimulates Fn production; however, neither TGF-β nor EGF produce Fn through a PKC-dependent pathway. EGF and TGF-β both stimulate Fn production at least in part through the intracellular signaling protein MAP-K. Understanding the signaling pathways involved in extracellular matrix protein production will allow the design of specific inhibitors of intimal hyperplasia.